Citation Impact
Citing Papers
Transcriptional Regulation by Nrf2
2017 Standout
DHA induces ER stress and growth arrest in human colon cancer cells: associations with cholesterol and calcium homeostasis
2008
Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism
2016
Cell type-selective secretome profiling in vivo
2020 StandoutNobel
FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling
2012
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations
2014
The adipose tissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms
2012
Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans
2017
Angiotensin II increases adipose angiotensinogen expression
2007
Hibiscus sabdariffa L. water extract inhibits the adipocyte differentiation through the PI3-K and MAPK pathway
2007
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
2014 Nature
Dissociating fatty liver and diabetes
2012
Hibiscus sabdariffa L. – A phytochemical and pharmacological review
2014 Standout
Hepatocellular carcinoma
2021 Standout
Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance
2011
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Non-alcoholic fatty liver disease
2021 Standout
The NRF2-KEAP1 Pathway Is an Early Responsive Gene Network in Arsenic Exposed Lymphoblastoid Cells
2014
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling
2017
Unraveling the Regulation of Hepatic Metabolism by Insulin
2017
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease
2020
Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond
2020
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Transcriptional regulation of hepatic lipogenesis
2015
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
AKT/PKB Signaling: Navigating the Network
2017 Standout
Type 2 diabetes mellitus
2015 Standout
Energy Metabolism in the Liver
2014 Standout
Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic
2014
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Increased carbonylation of the lipid phosphatase PTEN contributes to Akt2 activation in a murine model of early alcohol-induced steatosis
2013
NAFLD: A multisystem disease
2015 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Adipose Tissue as an Endocrine Organ
2004 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
2013
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance
2013
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
2014
Diabetic Cardiomyopathy
2018 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD
2020
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
The Role of Dietary Sugars and De novo Lipogenesis in Non-Alcoholic Fatty Liver Disease
2014
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
2018
Review article: the emerging role of genetics in precision medicine for patients with non‐alcoholic steatohepatitis
2020
Adipocyte Modulation of High-Density Lipoprotein Cholesterol
2010
Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle
2015 StandoutNobel
Adipose Tissue ATP Binding Cassette Transporter A1 Contributes to High-Density Lipoprotein Biogenesis In Vivo
2011
Regulation and Metabolic Significance of De Novo Lipogenesis in Adipose Tissues
2018
Works of Céline Robichon being referenced
Regulation of ABCA1 expression and cholesterol efflux during adipose differentiation of 3T3-L1 cells
2003
DnaJA4 is a SREBP-regulated chaperone involved in the cholesterol biosynthesis pathway
2006
Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes
2010
Insulin and Angiotensin II Induce the Translocation of Scavenger Receptor Class B, Type I from Intracellular Sites to the Plasma Membrane of Adipocytes
2005
The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans
2012